SIREN : 817468457
TRANSMED is a French company founded 10 years ago, specialized in the sector Transports de voyageurs par taxis. Based in MONTIGNY-LES-CORMEILLES (95370), this company of category PME shows in 2018 a revenue of 64 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Kennzahl | 2018 | 2017 | 2016 |
|---|---|---|---|
| Umsatz | 64 127 € | 61 536 € | 54 100 € |
| Nettoergebnis | 7 942 € | 3 150 € | 2 922 € |
| EBITDA | 10 054 € | 4 516 € | 3 919 € |
| Nettomarge | 12.4% | 5.1% | 5.4% |
In 2018, TRANSMED achieves revenue of 64 k€. Over the period 2016-2018, the company shows strong growth with a CAGR (compound annual growth rate) of +8.9%. Vs 2017: +4%. After deducting consumption (4 k€), gross margin stands at 60 k€, i.e. a rate of 93%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 10 k€, representing 15.7% of revenue. Positive scissor effect: EBITDA margin improves by +8.3 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 8 k€, i.e. 12.4% of revenue. This profit can be retained or distributed to shareholders.
64 127 €
59 854 €
10 054 €
9 385 €
7 942 €
15.5%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Cash flow represents 13.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
0.0%
13.423%
0.0
17.0%
In 2018, the debt ratio of TRANSMED (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2018, the financial autonomy of TRANSMED (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2018, the repayment capacity of TRANSMED (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 150.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.3x. Danger: operating income does not cover interest charges, unsustainable situation.
150.439
0.348
In 2018, the liquidity ratio of TRANSMED (150.44) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2018, the interest coverage of TRANSMED (0.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 54 days. Excellent situation: suppliers finance 54 days of the operating cycle (retail model). WCR is negative (-37 days): operations structurally generate cash. Over 2016-2018, WCR increased by +64%, requiring additional financing.
-6 669 €
0 j
54 j
0 j
-37 j
Based on 116 transactions of similar company sales (all years), the value of TRANSMED is estimated at 41 260 € (range 23 124€ - 78 515€). With an EBITDA of 10 054€, the sector multiple of 4.6x is applied. The price/revenue ratio is 0.61x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 116 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare TRANSMED with other companies in the same sector:
Voir toutes les statistiques du secteur Transports de voyageurs par taxis
The revenue of TRANSMED in 2018 is 64 k€.
Yes, TRANSMED generated a net profit of 8 k€ in 2018.
The headquarters of TRANSMED is located in MONTIGNY-LES-CORMEILLES (95370), in the department Val-d'Oise.
The tax return of TRANSMED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
TRANSMED operates in the sector Transports de voyageurs par taxis (NAF code 49.32Z). See the 'Sector positioning' section above to compare the company with its competitors.